See how AI medical-record review links every fact to the exact Bates page that proves it — click any citation and jump straight to the record.
See the 60-second demo →Medical malpractice litigation is expensive. A single case can cost $150,000–$500,000 to litigate — expert witnesses alone often run $50,000–$100,000 before you ever see a courtroom. For contingency-fee attorneys carrying a heavy docket, or for plaintiffs waiting years to see justice, those costs are crushing.
Litigation financing — also called legal finance or third-party funding — exists to solve exactly this problem. Funders pay case costs in exchange for a portion of the eventual recovery. If the case loses, the attorney or plaintiff owes nothing.
But getting approved is not automatic. Funders reject the majority of applications they receive. This guide explains precisely how to apply, what litigation finance firms actually want to see, and how AI-assisted case analysis is increasingly becoming the edge that separates funded applications from rejected ones.
Before diving into the application process, it is worth being precise about what you are applying for:
For most medical malpractice attorneys, the relevant product is single-case or portfolio funding from a commercial litigation funder.
The litigation finance industry is dominated by a handful of institutional players, plus a growing tier of mid-market firms:
| Funder | Focus | Min. Case Value |
|---|---|---|
| Burford Capital | Large commercial, IP, arbitration, malpractice portfolios | $10M+ |
| Omni Bridgeway | International arbitration, large U.S. commercial, malpractice | $5M+ |
| Litigation Capital Management (LCM) | U.S. and Australian commercial, personal injury portfolios | $2M+ |
| Validity Finance | Mid-market U.S. commercial and malpractice | $1M+ |
| Parabellum Capital | Personal injury, medical malpractice focus | $500K+ |
| Certum Group | Mass tort, medical device, pharmaceutical | $1M+ |
| Pravati Capital | Mid-size PI and malpractice | $250K+ |
For cases under $500K in expected recovery, institutional funders are typically not interested. Plaintiff-side advance companies (like Oasis Financial or Pre-Settlement Finance) fill that gap — but at much higher rates (often 2.5–4x the advance amount).
Litigation finance is essentially an investment decision. Funders underwrite the risk that your case produces a recovery large enough to repay the funding plus their return. They evaluate four things:
Is there clear, documentable negligence? Funders want to see a deviation from the standard of care that an expert can articulate simply. Complex causation chains, novel legal theories, or cases that require long explanations are harder to fund. The cleaner the liability, the better.
Are the damages quantifiable and substantial? Funders typically want to see expected recoveries of at least 3–5x the funding amount requested. A $500K case asking for $200K in funding is borderline. A $3M case asking for $200K is ideal from a risk-adjusted return standpoint.
Is there a defendant who can actually pay? Medical malpractice cases almost always have this — hospitals carry large policy limits, physicians are covered by professional liability insurance. The collectability question is usually answered quickly in med-mal.
How long will it take to get paid? Funders model IRR (internal rate of return), not just absolute returns. A case that settles in 18 months at $1M is far more attractive than one that goes to trial in 4 years and settles for $2M. Jurisdictions with faster trial calendars — and cases that show strong settlement pressure — get better terms.
Every funder application starts with a case summary — typically 5–15 pages. This document needs to cover:
After initial interest, funders request a document package. Be ready with:
There is no stigma in submitting to multiple funders at once. Most sophisticated attorneys run a competitive process. Submit to 3–5 funders in parallel, disclose this in your cover letter, and give them a 2–3 week deadline to respond with a term sheet.
Larger funders (Burford, Omni Bridgeway) move slowly — 6–12 weeks is common. Mid-market funders (Validity, Parabellum, Pravati) often have 2–4 week turnarounds. Adjust your process accordingly.
Funders issue a term sheet before finalizing their investment decision. Key terms to focus on:
After term sheet, funders conduct independent due diligence — often including their own medical expert review, legal merit analysis, and damages modeling. This typically takes 3–6 weeks. Be responsive to information requests and treat this phase as a final pitch, not a formality.
Funding agreements are typically 10–30 pages. Have independent counsel review before signing. Pay close attention to the definition of "net proceeds" (what gets deducted before the funder takes their share) and any provisions that could accelerate repayment.
The litigation finance industry has quietly become more data-driven over the past two years. Funders at firms like Burford and Omni Bridgeway employ PhD economists, actuaries, and data scientists alongside their legal teams. They increasingly want to see quantitative case analysis, not just narrative arguments.
This is where AI-assisted case preparation creates tangible leverage for attorneys:
A clear, complete medical timeline — pulling key events from hundreds or thousands of pages — is the foundation of every strong litigation finance application. AI tools that automatically extract dates, diagnoses, procedures, and clinical decisions from records can produce a funder-ready chronology in hours instead of days.
Medical malpractice cases often involve inflated billing that overstates the plaintiff's damages — or underbilling that understates them. An AI-generated CPT code audit that flags upcoding, unbundling, or duplicated charges makes the damages section of your application far more credible and defensible.
Funders care intensely about the strength of your experts. An AI tool that can cross-reference a proposed expert's publications, trial history, board certifications, and malpractice history provides the funder with objective credential analysis they would otherwise have to develop independently.
Funders model their expected return against settlement and verdict ranges in your jurisdiction for similar cases. AI-powered verdict databases that surface comparable outcomes — by injury type, jurisdiction, defendant category, and time period — give both the attorney and the funder a shared evidentiary basis for the damages estimate.
MedLegal AI generates organized medical record chronologies, CPT billing audits, and expert credential reports that funders actually want to see — cutting application prep time from weeks to days.
Start Your Free Trial →Based on patterns across the industry, applications fail most often for these reasons:
Litigation finance is legal in all U.S. jurisdictions, but rules around disclosure vary. Several states and federal districts require disclosure of litigation funding arrangements to opposing counsel or the court. The trend is toward more disclosure, not less.
Before entering a funding arrangement, confirm:
For institutional funders, 8–16 weeks from first submission to funded agreement is typical. Mid-market funders can move in 3–6 weeks. Emergency funding (when trial is imminent) is possible but comes at worse terms.
Return multiples of 2–3x the funded amount, or percentage-of-recovery arrangements of 20–35%, are most common. For high-value cases with strong liability, terms can be significantly better. For marginal cases, funders may demand more.
Reputable funders do not. Their agreements expressly disclaim any right to control litigation decisions, including settlement. This is ethically required in most jurisdictions. If a term sheet includes settlement control provisions, walk away.
Non-recourse funding means you owe nothing if the case is unsuccessful. The funder absorbs the loss. This is the fundamental value proposition of litigation finance.
This is an evolving area of tax law. Consult a tax attorney, but the general understanding is that funding advances are not taxable income when received — tax treatment occurs at recovery.
Litigation finance has matured into a sophisticated capital market. The firms deploying capital into medical malpractice cases are making data-driven underwriting decisions, and the applications that succeed are the ones that look like investment memoranda — organized, quantitative, and persuasive.
The attorneys who win funding consistently are those who have built the infrastructure to present their cases professionally at every stage: clean records, credible experts, defensible damages models, and clear liability narratives. AI tools increasingly make that infrastructure accessible to firms of any size.
If you are carrying malpractice cases and absorbing costs out of operating cash flow, you should be exploring litigation finance. The market is liquid, competition among funders is driving better terms, and the right cases fund faster today than they ever have before.
MedLegal AI helps you create the organized medical chronologies, billing audits, and expert reports that litigation finance firms require — faster than any human team can produce them alone.
Try MedLegal AI Free →Disclaimer: This article is for informational purposes only and does not constitute legal or financial advice. Consult qualified legal counsel before entering into any litigation finance arrangement.